New York, NY, March xxx, 2024 -- The Crohn's & Colitis Foundation seeks to accelerate the discovery and development of novel products with the potential to address the unmet needs of the 1 in 100 Americans affected by Crohn’s disease and ulcerative colitis, collectively known as Inflammatory Bowel Disease (IBD). From April 9-10, IBD INNOVATE: Product Development for Crohn’s & Colitis™, will spotlight innovative IBD products and bring key stakeholders together in Cambridge, MA to showcase emerging advances in IBD care.
Feature Presentations include:
- Keynote: Treatments for Intestinal Fibrosis in IBD- Florian Rieder, MD, Vice Chair, Department of Gastroenterology, Hepatology and Nutrition; Investigator at Department of Pathobiology, Cleveland Clinic, Cleveland, OH
- Synthetic Biology and the Future of IBD: Timothy L. Lu, MD, PhD, Senti Bio, Co-founder and CEO
- The IBD Investment Landscape–Challenges and Opportunities- Tom Shehab, MD, Managing Partner at Arboretum Ventures
- Cell Therapy for Fistulizing Crohn's Disease: Current State and Future Directions-Amy Lightner, MD, Professor of Surgery, Scripps Research Institute
- A Novel Agent Targeting Neutrophils: Advancing the Treatment of IBD- Rena Gupta, MD, Chief Medical Officer, Adiso Therapeutics
Don’t miss the IBD Innovate Shark Tank event where five pioneering companies will pitch their groundbreaking healthcare products and services. This event is an exceptional networking opportunity for all stakeholders dedicated to advancing innovative products to address the critical challenges IBD patients face. Click here for the full agenda.
WHO: Startup companies, academic researchers, investors, clinicians, patient advocates, journalists, and more are invited to participate.
WHERE: MassBio, 700 Technology Square, Cambridge, MA 02139
WHEN: Tuesday, April 9- Wednesday, April 10
The Crohn’s & Colitis Foundation is the leading nonprofit organization focused on both research and patient support for inflammatory bowel disease (IBD), with the mission of curing Crohn’s disease and ulcerative colitis and improving the quality of life for the millions of Americans living with IBD. The Foundation’s work is dramatically accelerating the research process, while also providing extensive educational and support resources for patients and their families, medical professionals, and the public.
New York, NY, March xxx, 2024 -- The Crohn's & Colitis Foundation seeks to accelerate the discovery and development of novel products with the potential to address the unmet needs of the 1 in 100 Americans affected by Crohn’s disease and ulcerative colitis, collectively known as Inflammatory Bowel Disease (IBD). From April 9-10, IBD INNOVATE: Product Development for Crohn’s & Colitis™, will spotlight innovative IBD products and bring key stakeholders together in Cambridge, MA to showcase emerging advances in IBD care.
Feature Presentations include:
- Keynote: Treatments for Intestinal Fibrosis in IBD- Florian Rieder, MD, Vice Chair, Department of Gastroenterology, Hepatology and Nutrition; Investigator at Department of Pathobiology, Cleveland Clinic, Cleveland, OH
- Synthetic Biology and the Future of IBD: Timothy L. Lu, MD, PhD, Senti Bio, Co-founder and CEO
- The IBD Investment Landscape–Challenges and Opportunities- Tom Shehab, MD, Managing Partner at Arboretum Ventures
- Cell Therapy for Fistulizing Crohn's Disease: Current State and Future Directions-Amy Lightner, MD, Professor of Surgery, Scripps Research Institute
- A Novel Agent Targeting Neutrophils: Advancing the Treatment of IBD- Rena Gupta, MD, Chief Medical Officer, Adiso Therapeutics
Don’t miss the IBD Innovate Shark Tank event where five pioneering companies will pitch their groundbreaking healthcare products and services. This event is an exceptional networking opportunity for all stakeholders dedicated to advancing innovative products to address the critical challenges IBD patients face. Click here for the full agenda.
WHO: Startup companies, academic researchers, investors, clinicians, patient advocates, journalists, and more are invited to participate.
WHERE: MassBio, 700 Technology Square, Cambridge, MA 02139
WHEN: Tuesday, April 9- Wednesday, April 10
The Crohn’s & Colitis Foundation is the leading nonprofit organization focused on both research and patient support for inflammatory bowel disease (IBD), with the mission of curing Crohn’s disease and ulcerative colitis and improving the quality of life for the millions of Americans living with IBD. The Foundation’s work is dramatically accelerating the research process, while also providing extensive educational and support resources for patients and their families, medical professionals, and the public.